Inventor · disambiguated record
Sanjeev Gangwar
Also filed as: GANGWAR SANJEEV
74 granted patents·19 pending applications·1,691 citations·filing 1995–2024
99Inventor score
Files withBRISTOL MYERS SQUIBB CO56MEDAREX INC24UNIV RICE WILLIAM M3JUVA LIFE INC2SQUIBB & SONS LLC2
Top patents by PatentIndex Score
93 records- 0198US7517903B2Cytotoxic compounds and conjugatesMEDAREX INC·Filed 2005·Granted Apr 14, 2009·161 cites·19 claims
- 0298US7507420B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2005·Granted Mar 24, 2009·148 cites·32 claims
- 0398US7087600B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2002·Granted Aug 8, 2006·259 cites·32 claims
- 0497US8980824B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 17, 2015·35 cites·19 claims
- 0597US7714016B2Cytotoxic compounds and conjugates with cleavable substratesMEDAREX INC·Filed 2006·Granted May 11, 2010·45 cites·21 claims
- 0696US10457681B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 29, 2019·15 cites·9 claims
- 0796US7977465B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2009·Granted Jul 12, 2011·14 cites·21 claims
- 0896US7968586B2Cytotoxic compounds and conjugatesMEDAREX INC·Filed 2006·Granted Jun 28, 2011·39 cites·18 claims
- 0996US7691962B2Chemical linkers and conjugates thereofMEDAREX INC·Filed 2005·Granted Apr 6, 2010·200 cites·47 claims
- 1095US10869934B2Antiproliferative compounds and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 22, 2020·8 cites·1 claims
- 1195US10487084B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 26, 2019·16 cites·15 claims
- 1295US10472361B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 12, 2019·16 cites·6 claims
- 1395US8394922B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofCHENG HENG·Filed 2010·Granted Mar 12, 2013·67 cites·26 claims
- 1495US7847105B2Methods and compounds for preparing CC-1065 analogsMEDAREX INC·Filed 2006·Granted Dec 7, 2010·33 cites·15 claims
- 1594US10508115B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 17, 2019·13 cites·19 claims
- 1694US10494370B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 3, 2019·15 cites·6 claims
- 1794US8709431B2Enediyne compounds, conjugates thereof, and uses and methods thereforBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 29, 2014·24 cites·16 claims
- 1894US7329507B2Prodrug compounds with isoleucineMEDAREX INC·Filed 2006·Granted Feb 12, 2008·27 cites·5 claims
- 1994US7115573B2Prodrug compounds with an isoleucineMEDAREX INC·Filed 2001·Granted Oct 3, 2006·61 cites·41 claims
- 2093US10898578B2Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and makingBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 26, 2021·4 cites·21 claims
- 2193US9526801B2Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and usingBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 27, 2016·13 cites·41 claims
- 2293US9109008B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 18, 2015·7 cites·2 claims
- 2393US8461117B2Chemical linkers and cleavable substrates and conjugates thereofSUFI BILAL·Filed 2007·Granted Jun 11, 2013·61 cites·9 claims
- 2493US7214663B2Tripeptide prodrug compoundsMEDAREX INC·Filed 2001·Granted May 8, 2007·52 cites·26 claims
- 2593US6897034B2CD10-activated prodrug compoundsMEDAREX INC·Filed 2002·Granted May 24, 2005·52 cites·10 claims
- 2692US11400094B22H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 2, 2022·4 cites·18 claims
- 2792US8664407B2Chemical linkers with single amino acids and conjugates thereofCHEN LIANG·Filed 2008·Granted Mar 4, 2014·26 cites·7 claims
- 2891US9382289B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 5, 2016·5 cites·7 claims
- 2991US8802632B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofMEDAREX INC·Filed 2013·Granted Aug 12, 2014·12 cites·13 claims
- 3091US7425541B2Enzyme-cleavable prodrug compoundsMEDAREX INC·Filed 2001·Granted Sep 16, 2008·37 cites·23 claims
- 3190US8852599B2Immunoconjugates, compositions for making them, and methods of making and useZHANG QIAN·Filed 2012·Granted Oct 7, 2014·21 cites·20 claims
- 3290US8034787B2Enzyme-cleavable prodrug compoundsMEDAREX INC·Filed 2008·Granted Oct 11, 2011·8 cites·17 claims
- 3390US7304032B2CD-10 activated prodrug compoundsMEDAREX INC·Filed 2004·Granted Dec 4, 2007·31 cites·23 claims
- 3489US10398783B2Antiproliferative compounds and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 3, 2019·7 cites·4 claims
- 3589US9580467B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofSQUIBB & SONS LLC·Filed 2015·Granted Feb 28, 2017·5 cites·1 claims
- 3689US7816317B2Tripeptide prodrug compoundsMEDAREX INC·Filed 2007·Granted Oct 19, 2010·13 cites·26 claims
- 3788US5672584ACyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeabilityUNIV KANSAS·Filed 1995·Granted Sep 30, 1997·97 cites·5 claims
- 3887US9527871B2Benzodiazepine dimers, conjugates thereof, and methods of making and usingBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 27, 2016·5 cites·43 claims
- 3987US7696313B2Prodrug compounds with isoleucineMEDAREX INC·Filed 2008·Granted Apr 13, 2010·7 cites·10 claims
- 4086US11554120B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 17, 2023·4 cites·13 claims
- 4186US9688721B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 27, 2017·2 cites·1 claims
- 4285US9676794B2Benzodiazepine dimers, conjugates thereof, and methods of making and usingBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 13, 2017·3 cites·1 claims
- 4385USRE41252EPeptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2008·Granted Apr 20, 2010·3 cites·32 claims
- 4481US9777013B2Derivatives of uncialamycin, methods of synthesis and their use as antitumor agentsUNIV RICE WILLIAM M·Filed 2014·Granted Oct 3, 2017·4 cites·21 claims
- 4581US9156850B2Enediyne compounds, conjugates thereof, and uses and methods thereforBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 13, 2015·4 cites·7 claims
- 4680US9226974B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofSQUIBB & SONS LLC·Filed 2014·Granted Jan 5, 2016·2 cites·8 claims
- 4780US2024165249A1Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and makingBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 4877US10723736B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·0 cites·1 claims
- 4977US10711003B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 5075US8772542B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofMEDAREX INC·Filed 2013·Granted Jul 8, 2014·1 cites·10 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →